UB Paderborn / Katalog / Suche / in CDI

Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register

Clinical endocrinology (Oxford), 2009-09, Vol.71 (3), p.400-405

2009

Link zum Volltext

Verfügbarkeit prüfen

The German Acromegaly Registry: description of the database and initial results

Experimental and clinical endocrinology & diabetes, 2006-10, Vol.114 (9), p.498

2006

Link zum Volltext

Verfügbarkeit prüfen

Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study

Acta neurochirurgica, 2005-05, Vol.147 (5), p.485-493

2005

Link zum Volltext

Verfügbarkeit prüfen

Acromegaly and end-stage renal disease: a diagnostic challenge

Journal of endocrinological investigation, 2006-09, Vol.29 (8), p.745-749

2006

Link zum Volltext

Verfügbarkeit prüfen

Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas : effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy

The journal of clinical endocrinology and metabolism, 1994-11, Vol.79 (5), p.1416-1423

1994

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal side-effects of octreotide during long term treatment of acromegaly

The journal of clinical endocrinology and metabolism, 1990-12, Vol.71 (6), p.1658-1662

1990

Link zum Volltext

Verfügbarkeit prüfen

Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register

European journal of endocrinology, 2008-11, Vol.159 (5), p.525

2008

Link zum Volltext

Verfügbarkeit prüfen

Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly

The journal of clinical endocrinology and metabolism, 1989-05, Vol.68 (5), p.873-881

1989

Link zum Volltext

Verfügbarkeit prüfen

Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects

European journal of endocrinology, 1999-06, Vol.140 (6), p.538

1999

Link zum Volltext

Verfügbarkeit prüfen

TREATMENT OF ACROMEGALY BY TRANS-SPHENOIDAL OPERATION, 90-YTTRIUM IMPLANTATION AND BROMOCRIPTINE: RESULTS IN 230 PATIENTS

Clinical endocrinology (Oxford), 1982-02, Vol.16 (2), p.107-119

QUABBE, H-J.

1982

Link zum Volltext

Verfügbarkeit prüfen

Metabolic aspects of acromegaly and its treatment

Metabolism, clinical and experimental, 1996-08, Vol.45 (8 Suppl 1), p.61-62

1996

Link zum Volltext

Verfügbarkeit prüfen

Effect of the somatostatin analog octreotide on gastric mucosal function and histology during 3 months of preoperative treatment in patients with acromegaly

European journal of endocrinology, 1998-10, Vol.139 (4), p.387

1998

Link zum Volltext

Verfügbarkeit prüfen

TWENTY-FOUR-HOUR PROFILES OF GROWTH HORMONE, PROLACTIN AND CORTISOL IN THE CHRONIC VEGETATIVE STATE

Clinical endocrinology (Oxford), 1990-11, Vol.33 (5), p.631-643

1990

Link zum Volltext

Verfügbarkeit prüfen

Hypothalamic modulation of growth hormone secretion in the rhesus monkey : evidence from intracerebroventricular infusions of glucose, free fatty acid, and ketone bodies

The journal of clinical endocrinology and metabolism, 1991-10, Vol.73 (4), p.765-770

1991

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR®) for the treatment of acromegaly

Journal of endocrinological investigation, 1991-12, Vol.14 (11), p.943-948

1991

Link zum Volltext

Verfügbarkeit prüfen

Octreotide long term treatment of acromegaly : effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values

The journal of clinical endocrinology and metabolism, 1993-07, Vol.77 (1), p.157-162

1993

Link zum Volltext

Verfügbarkeit prüfen

Plasma glucose and free fatty acids modulate the secretion of growth hormone, but not prolactin, in the rhesus and Java monkey

The journal of clinical endocrinology and metabolism, 1990-04, Vol.70 (4), p.908-915

1990

Link zum Volltext

Verfügbarkeit prüfen

Clinical aspects of growth hormone excess: achievements and problems

The Journal of pediatric endocrinology, 1993, Vol.6 (3-4), p.333

Quabbe, H J

1993

Link zum Volltext

Verfügbarkeit prüfen

Hypothalamic control of GH secretion: pathophysiology and clinical implications

Acta neurochirurgica, 1985-03, Vol.75 (1-4), p.60-71

QUABBE, H.-J

1985

Link zum Volltext

Verfügbarkeit prüfen

Risiko in der Chirurgie: Stoffwechselerkrankungen (Diabetes mellitus, Adipositas)

Risiko in der Chirurgie, 2019, p.139-148

Originally published 1987, 2019

Link zum Volltext

Verfügbarkeit prüfen

Influence of ketone body infusion on plasma growth hormone and glucagon in man

The journal of clinical endocrinology and metabolism, 1983-09, Vol.57 (3), p.613-618

1983

Link zum Volltext

Verfügbarkeit prüfen

Nocturnal growth hormone secretion: correlation with sleeping EEG in adults and pattern in children and adolescents with non-pituitary dwarfism, overgrowth and with obesity

Acta endocrinologica (Copenhagen), 1971-01, Vol.67 (4), p.767

1971

Link zum Volltext

Verfügbarkeit prüfen

Behandlung der Akromegalie

Deutsche medizinische Wochenschrift, 1982, Vol.107 (27), p.1060-1063

Quabbe, H.-J.

1982

Link zum Volltext

Verfügbarkeit prüfen

Effect of human proinsulin on blood glucose control and metabolic instability in type 1 diabetes mellitus

Diabetes research (Edinburgh, Scotland), 1989-04, Vol.10 (4), p.165

1989

Link zum Volltext

Verfügbarkeit prüfen

Pattern of growth hormone secretion during a 24-hour fast in normal adults

The journal of clinical endocrinology and metabolism, 1966-10, Vol.26 (10), p.1173-1177

1966

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register

The German Acromegaly Registry: description of the database and initial results

Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study

Acromegaly and end-stage renal disease: a diagnostic challenge

Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas : effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy

Gastrointestinal side-effects of octreotide during long term treatment of acromegaly

Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register

Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly

Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects

TREATMENT OF ACROMEGALY BY TRANS-SPHENOIDAL OPERATION, 90-YTTRIUM IMPLANTATION AND BROMOCRIPTINE: RESULTS IN 230 PATIENTS

Metabolic aspects of acromegaly and its treatment

Effect of the somatostatin analog octreotide on gastric mucosal function and histology during 3 months of preoperative treatment in patients with acromegaly

TWENTY-FOUR-HOUR PROFILES OF GROWTH HORMONE, PROLACTIN AND CORTISOL IN THE CHRONIC VEGETATIVE STATE

Hypothalamic modulation of growth hormone secretion in the rhesus monkey : evidence from intracerebroventricular infusions of glucose, free fatty acid, and ketone bodies

Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR®) for the treatment of acromegaly

Octreotide long term treatment of acromegaly : effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values

Plasma glucose and free fatty acids modulate the secretion of growth hormone, but not prolactin, in the rhesus and Java monkey

Clinical aspects of growth hormone excess: achievements and problems

Hypothalamic control of GH secretion: pathophysiology and clinical implications

Risiko in der Chirurgie: Stoffwechselerkrankungen (Diabetes mellitus, Adipositas)

Influence of ketone body infusion on plasma growth hormone and glucagon in man

Nocturnal growth hormone secretion: correlation with sleeping EEG in adults and pattern in children and adolescents with non-pituitary dwarfism, overgrowth and with obesity

Behandlung der Akromegalie

Effect of human proinsulin on blood glucose control and metabolic instability in type 1 diabetes mellitus

Pattern of growth hormone secretion during a 24-hour fast in normal adults

Suchergebnisse filtern